Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Dena E, Cohen"'
Autor:
Dena E. Cohen, Kathryn S. Gray, Carey Colson, David B. Van Wyck, Francesca Tentori, Steven M. Brunelli
Publikováno v:
Kidney Medicine, Vol 2, Iss 1, Pp 12-19 (2020)
Rationale & Objective: Among patients treated with in-center hemodialysis (HD), missed treatments are associated with higher subsequent rates of hospitalization and other adverse outcomes compared with attending treatment. The objective of this study
Externí odkaz:
https://doaj.org/article/d6a8bbf8cd634e8f9a75a1093e30a087
Autor:
Dena E. Cohen, Andrew Lee, Scott Sibbel, Deborah Benner, Steven M. Brunelli, Francesca Tentori
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-9 (2019)
Abstract Background Health-related quality of life (HRQOL) is a key outcome for dialysis patients, and its assessment is mandated by the Centers for Medicaid and Medicare Services. The Kidney Disease Quality of Life (KDQOL-36™) survey is widely use
Externí odkaz:
https://doaj.org/article/5181f6dc658045a0823227c02999cd80
Autor:
Dena E. Cohen, Andrew Lee, Scott Sibbel, Deborah Benner, Steven M. Brunelli, Francesca Tentori
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-2 (2019)
Abstract In their correspondence, Hays et al. raise two main critiques of our recently published article entitled “Use of the KDQOL-36™ for assessment of health-related quality of life among dialysis patients in the United States.” First, Hays
Externí odkaz:
https://doaj.org/article/551e8ad2cf124f25800797fe0233fafe
Autor:
Dena E. Cohen, Andrew Lee, Scott Sibbel, Deborah Benner, Steven M. Brunelli, Francesca Tentori
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-2 (2019)
Following publication of the original article [1], the authors reported an error in Figs. 3 and S3.
Externí odkaz:
https://doaj.org/article/07d1b8181d8e493bb9b2762799e2f070
Autor:
Dena E Cohen
Publikováno v:
Birth (Berkeley, Calif.)REFERENCE.
Autor:
Steph Karpinski, Scott Sibbel, Dena E Cohen, Carey Colson, David B Van Wyck, Arshia Ghaffari, Martin J Schreiber, Steven M. Brunelli, Francesca Tentori
Publikováno v:
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
The majority of end-stage kidney disease (ESKD) patients start dialysis without adequate pre-dialysis planning. Of these patients, the vast majority initiate in-centre haemodialysis using a central venous catheter (ICHD-CVC). A minority utilise urgen
Autor:
David Van Wyck, Levi Njord, Gilbert Marlowe, Dena E. Cohen, Steven M. Brunelli, Daniel Liu, George R. Aronoff
Publikováno v:
Journal of Nephrology. 32:453-460
Heparin is widely used to prevent coagulation during hemodialysis. Although systemic anticoagulants and antiplatelet agents are commonly prescribed in the hemodialysis population, the safety and efficacy of heparin in the presence of these medication
Autor:
Jeffrey J. Connaire, Gilbert Marlowe, Dena E. Cohen, Dawn Miller, Francesca Tentori, Steven M. Brunelli, Amy E. Young, Tara Kelley, Scott Sibbel, Kelsey Bludorn
Publikováno v:
J Am Soc Nephrol
BACKGROUND: Although reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rare among individuals with few coronavirus disease 2019 (COVID-19) risk factors, the ability of naturally acquired immunity to prevent reinfection
Autor:
N. Queija, S. Zeig, K. Swanzy, J. L. Posada, Dena E. Cohen, J. A. Fernandez-Bombino, P. M. Teixeiro, Steven M. Brunelli, M. T. Lemont, L. Garcia-Mayol, M. J. Palecek, Gilbert Marlowe, Zain Mithani, M. A. Sosa, J. A. Giullian, Oliver Lenz, Gabriel Contreras, Mahesh Krishnan, Jair Munoz Mendoza, A. M. V. Miles, J. S. Jeanty
IntroductionThe coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Although tests to detect anti-SARS-CoV-2 antibodies have been developed, their sensitivity and specifici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2269980407897378c8639f03725ddd5e
https://doi.org/10.1101/2020.08.03.20163642
https://doi.org/10.1101/2020.08.03.20163642
Publikováno v:
Journal of Nephrology. 31:577-584
It is widely thought that patients with end-stage renal disease who remain vocationally active and/or commercially insured following dialysis initiation have better clinical outcomes and higher quality of life than those who do not. However, scientif